Search ResultsElectronic Resources
by
Singh, Udai, author.
Format:
Excerpt:
Studies on Chemotherapy and Biochemical Behaviour of Anti-Cancerous Drugs / Singh, Udai, author.
by
Lederer, Nirosha Mahendraratnam, author.
Format:
Excerpt:
Optimizing Antiemetic Use in Patients Initiating Highly Emetogenic Intravenous Chemotherapy
by
Whang, Chang-Hee, author.
Format:
Excerpt:
forms of chemotherapy.
by
Uddin, Mohammad Burhan, author.
Format:
Excerpt:
cancer stem cell behavior, invasiveness, metastasis and resistance to chemotherapy. Targeting mutant p53
by
Reilly, Nicole M., author.
Format:
Excerpt:
characteristic of cancer. However, the status of these same genes can also determine chemotherapy outcomes. RAD51
by
Karim, Mohammad Anwarul, author.
Format:
Excerpt:
antifolate chemotherapy, it is necessary to develop agents which are selective for the cancerous tissues
by
Stocke, Nathanael A., author.
Format:
Excerpt:
were formulated with two common ACAs, cisplatin and erlotinib, for inhalable chemotherapy. The activity
by
Henderson, Elizabeth D., author.
Format:
Excerpt:
diagnosis in the United States in 2017. While chemotherapy is the primary treatment option for cancer
by
Park, Joonyoung, author.
Format:
Excerpt:
efficacy of systemic chemotherapy, but clinical translation of nanoparticle drug carriers has been slow
by
Miles, Jana S., author.
Format:
Excerpt:
advanced. For this reason, cytotoxic chemotherapy is used as a last resort to treat advanced neoplasias
by
Hedrich, William Dominic, author.
Format:
Excerpt:
chemotherapy for NHL. CHOP chemotherapy has been associated with severe and cumulative cardiotoxicity arising
by
Poku, Rosemary A., author.
Format:
Excerpt:
. Metastatic castration-resistant prostate cancer (mCRPC) poses a major challenge to chemotherapy and it





